NCT01522391 - A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Atopic Dermatitis

Interventions

DRUG

DPK-060 1% ointment

DPK-060 1% ointment applied to the skin, two applications per day using approximately 3 mg ointment per cm2

DRUG

Placebo for DPK-060 ointment

Placebo for DPK-060 ointment applied to the skin, two applications per day using approximately 3 mg ointment per cm2

Trial Locations (1)

Quintiles Hermelinen AB, Luleå